| Phase 2 |
| NCT03796884 |
Linaclotide in Treating Patients With Stages 0-3 Colorectal Cancer |
Colorectal Adenoma |
Active, Not Recruiting |
2026-10-08 |
| NCT03198026 |
Obinutuzumab and Ibrutinib as Front Line Therapy in Treating Patients With Indolent… |
Non-Hodgkin's Lymphoma |
Active, Not Recruiting |
2026-08-18 |
| NCT02068586 |
Sunitinib Malate or Valproic Acid in Preventing Metastasis in Patients With High-Risk… |
Ciliary Body and Choroid Melanoma, Medium/Large Size |
Active, Not Recruiting |
2026-03-16 |
| Phase 1 |
| NCT01655836 |
High-Dose Rate Brachytherapy and Stereotactic Body Radiation Therapy in Treating Patients… |
Prostate Cancer |
Active, Not Recruiting |
2026-10-02 |
| Not applicable |
| NCT03184038 |
Neurocognition in Patients With Multiple Brain Metastases Treated With Radiosurgery |
Metastatic Malignant Neoplasm in the Brain |
Recruiting |
2026-05-22 |
| NCT07501663 |
Optimizing Integrative Oncology Approaches to Address Chemotherapy-induced Peripheral… |
Peripheral Neuropathy |
Recruiting |
2026-04-14 |
| NCT02757859 |
WASH Trial: Intraoperative Lavage as a Treatment for Pancreatic Cancer |
Acinar Cell Carcinoma |
Active, Not Recruiting |
2026-05-29 |
| NCT03251027 |
Intensity-Modulated Stereotactic Radiation Therapy in Treating Patients With Grade II-IV… |
Glioblastoma |
Active, Not Recruiting |
2026-01-27 |
| Not specified |
| NCT06974981 |
Leveraging Lung Cancer Screening to Optimize Screening Outcomes and COPD Management: COPD… |
COPD |
Recruiting |
2026-03-03 |